Cite
MLA Citation
Dennis A. Eichenauer et al.. “Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.” Hematological oncology, vol. 40, no. 4, 2022, pp. 801–804. http://access.bl.uk/ark:/81055/vdc_100167908071.0x000049